🇺🇸 FDA
Patent

US 11964010

Prefusion coronavirus spike proteins and their use

granted A61KA61K39/12A61K39/215

Quick answer

US patent 11964010 (Prefusion coronavirus spike proteins and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K39/12, A61K39/215, A61P, A61P31/14